GMO Quarterly Update Q2 2014

download GMO Quarterly Update Q2 2014

of 62

Transcript of GMO Quarterly Update Q2 2014

  • 8/12/2019 GMO Quarterly Update Q2 2014

    1/62

    GMO offers institutionally-oriented global investment strategies. For client inquiries, please contact your Client RelationshipManager. For new business inquiries, please contact your Relationship Manager or Holly Carson at (617) 346-7501 [email protected]

    This is not an offer or solicitation for the purchase or sale of any security and should not be construed as such.

  • 8/12/2019 GMO Quarterly Update Q2 2014

    2/62

    GMO Capabilit ies

    * Certain GMO capabilities are not available through separately managed accounts and therefore information on those capabilities are not included inthis document. For information please contact GMO.

    GMO Multi-Asset Class Page

    Benchmark-Free Allocation 4

    Global Allocation Absolute Return 6

    Global Asset Allocation 8

    Real Return Global Balanced Asset Allocation 10

    Tax-Managed Global Balanced 12

    GMO Global Equities Page

    Global All Country Equity All ocation 14

    Global Developed Equity Allocation 16

    Global Focused Equity 18

    Quality 20

    Resources 22

    GMO International Equities Page

    International All Country Equity Allocation 24

    International Developed Equity All ocation 26

    Tax-Managed International Equi ties*

    International Equity 28

    International Active EAFE 30

    International Active Foreign Small Companies 32

    International Small Companies*

    GMO U.S. Equities Page

    U.S. Equity Allocation 34

    GMO Emerging Equities Page

    Emerging Markets 36

    Emerging Countries*

    Emerging Domestic Opportunities 38

    GMO Fixed Income Page

    Global Bond 40

    International Bond 42

    Currency Hedged International Bond 44

    Core Plus Bond 46

    Emerging Country Debt*

    Emerging Country Local Debt*

    Debt Opportunities 48

    GMO Absolute Return Page

    Emerging Country Debt Long/Short*

    Fixed Income Hedge 50

    Mean Reversion 52

    Systematic Global Macr o 54

    Tactical Opportunities 56

    Total Equities 58

    Multi-Strategy*

    1

  • 8/12/2019 GMO Quarterly Update Q2 2014

    3/62

    2014 Performance of GMO Strategies and Benchmarks

    Performance data quoted represents past performance and is not predictive of future performance. Returns are shown after the deduction ofmanagement fees, transaction costs and other expenses, but before custody charges, withholding taxes, and other indirect expenses. The returns assumethe reinvestment of dividends and other income.

    Copyright 2014 by GMO. All rights reserved. This document may not be reproduced, distributed or transmitted, in whole or in portion, by anymeans, without written permission from GMO.

    otal Return Net of Fees Average Annual Total Return

    GMO Multi-Asset Class Inception 2Q YTD YTD Value One Five Ten SinceStrategies/Benchmarks Date 2014 2014 Added Year Year Year Inception

    Benchmark-Free Allocation 7/31/01 3.43 4.69 3.36 11.83 9.39 9.33 11.28

    CPI 0.87 1.33 2.04 2.08 2.30 2.29

    Global Allocation Absolute Return 7/31/01 3.22 4.42 3.10 10.97 8.28 8.39 9.85CPI 0.87 1.33 2.04 2.08 2.30 2.29

    Global Asset Allocation 6/30/88 3.70 5.47 0.02 14.81 10.86 7.59 9.96

    Blended Benchmark 3.99 5.45 16.25 11.23 6.40 8.31

    Real Return Global Balanced Asset Alloc. 6/30/04 3.26 5.25 0.72 13.91 9.79 7.62 7.62

    Blended Benchmark 3.31 4.53 14.96 10.08 5.95 5.95

    Tax-Managed Global Balanced 12/31/02 2.92 4.61 -0.85 13.40 8.92 6.90 8.12

    GMO Tax-Managed Global Balanced Index 3.89 5.46 15.71 10.93 6.33 7.48

    GMO Global Equities Inception 2Q YTD YTD Value One Five Ten SinceStrategies/Benchmarks Date 2014 2014 Added Year Year Year Inception

    Global All Country Equity Allocation 12/31/93 4.91 7.06 0.87 22.57 14.13 8.79 9.58

    Blended Benchmark 5.04 6.19 23.10 14.62 7.35 7.73

    Global Developed Equity Allocation 3/31/87 4.79 7.58 1.40 24.57 14.87 8.44 9.79

    Blended Benchmark 4.86 6.18 24.05 15.00 7.13 7.64

    Global Focused Equity 12/31/11 5.38 6.15 -0.03 32.21 N/A N/A 22.72

    MSCI ACWI 5.04 6.18 22.95 N/A N/A 18.05

    Quality 2/29/04 3.69 5.77 -1.36 17.59 15.85 6.89 6.71

    S&P 500 5.23 7.14 24.61 18.83 7.78 7.54

    Resources 12/31/11 10.58 11.86 2.47 29.14 N/A N/A 10.22

    MSCI ACWI Commodity Producers 9.28 9.39 24.97 N/A N/A 5.83

    GMO International Equities Inception 2Q YTD YTD Value One Five Ten SinceStrategies/Benchmarks Date 2014 2014 Added Year Year Year Inception

    International All Country Equity Alloc. 2/28/94 5.91 7.89 2.35 26.40 12.16 8.72 8.20

    Blended Benchmark 5.01 5.54 21.78 11.07 7.69 6.17

    Inter national Devel oped Equity Al location 11/30/91 5.54 9.02 4.24 30.16 13.28 8.31 8.96

    Blended Benchmark 4.09 4.78 23.57 11.82 7.20 6.79

    International Equity 3/31/87 5.22 8.73 2.72 32.01 11.75 7.07 8.62

    MSCI EAFE + 4.73 6.01 26.86 11.24 6.71 7.48

    MSCI EAFE 4.09 4.78 23.57 11.77 6.93 6.18

    International Active EAFE 5/31/81 2.99 1.93 -2.85 21.97 10.39 6.34 12.15

    MSCI EAFE 4.09 4.78 23.57 11.77 6.93 9.32

    Int'l. Active Foreign Small Companies 1/31/95 1.90 5.02 -2.22 25.85 17.31 11.13 11.94

    S&P Developed ex-U.S. Small Cap 3.40 7.24 29.95 15.47 9.64 7.90

    GMO U.S. Equities Inception 2Q YTD YTD Value One Five Ten SinceStrategies/Benchmarks Date 2014 2014 Added Year Year Year Inception

    U.S. Equity Allocation 2/28/89 3.34 5.53 -1.60 18.05 16.46 6.90 10.83

    Blended Benchmark 5.23 7.14 24.86 19.15 8.05 10.36

    2

  • 8/12/2019 GMO Quarterly Update Q2 2014

    4/62

    2014 Performance of GMO Strategies and Benchmarks

    Performance data quoted represents past performance and is not predictive of future performance. Returns are shown after the deduction ofmanagement fees, transaction costs and other expenses, but before custody charges, withholding taxes, and other indirect expenses. The returns assumethe reinvestment of dividends and other income.

    * Returns for one of the accounts in the composite are based on estimated market values for the period from and including October 2008 through February 2009.

    otal Return Net of Fees Average Annual Total Return

    GMO Emerging Equities Inception 2Q YTD YTD Value One Five Ten SinceStrategies/Benchmarks Date 2014 2014 Added Year Year Year Inception

    Emerging Markets 12/31/93 8.13 4.95 -1.87 13.39 8.51 11.07 8.05

    S&P/IFCI Composite 7.51 6.82 16.00 10.14 12.91 6.28

    MSCI Emerging Markets 6.60 6 .14 14.31 9.24 11.94 5 .66Emerging Domestic Opportunities 3/31/11 5.60 2.94 -3.20 5.56 N/A N/A 6.01

    MSCI Emerging Markets 6.60 6.14 14.31 N/A N/A -0.71

    GMO Fixed Income Inception 2Q YTD YTD Value One Five Ten SinceStrategies/Benchmarks Date 2014 2014 Added Year Year Year Inception

    Global Bond* 12/31/95 3.07 7.33 2.28 8.97 9.22 5.20 6.04

    J.P. Morgan GBI Global 2.28 5.05 6.50 3.80 4.96 5.24

    International Bond 12/31/93 3.43 8.80 2.73 12.88 9.91 5.92 7.23

    J.P. Morgan GBI Global ex U.S. 2.68 6.07 8.92 3.80 5.06 5.72

    Currency Hedged Int'l. Bond 9/30/94 3.00 8.03 1.91 8.81 9.88 5.37 7.98

    J.P. Morgan GBI Global 2.62 6.12 7.56 5.46 5.38 6.91

    ex-Japan ex U.S. (Hedged) +Core Plus Bond 4/30/97 2.59 5.74 1.81 6.44 9.90 5.06 6.10

    Barclays U.S. Aggregate 2.04 3.93 4.37 4.85 4.93 5.81

    Debt Opportunities 10/31/11 1.70 3.19 3.02 6.08 N/A N/A 7.84

    J.P. Morgan U.S. 3 Month Cash 0.08 0.17 0.36 N/A N/A 0.57

    GMO Absolute Return Inception 2Q YTD YTD Value One Five Ten SinceStrategies/Benchmarks Date 2014 2014 Added Year Year Year Inception

    Fixed Income Hedge 8/31/05 1.40 5.99 5.81 2.51 8.96 N/A -0.34

    J.P. Morgan U.S. 3 Month Cash 0.08 0.17 0.36 0.53 N/A 2.26

    Mean Reversion 2/28/02 -0.84 0.06 0.04 -4.29 0.30 4.49 7.17

    Citigroup 3-Mo. T-Bill 0.01 0.02 0.04 0.08 1.54 1.49

    Systematic Global Macro 3/31/02 -0.67 1.41 1.39 4.79 7.11 6.71 7.34

    Citigroup 3-Mo. T-Bill 0.01 0.02 0.04 0.08 1.54 1.49

    Tactical Opportunities 9/30/04 -5.01 -7.51 -7.53 -14.93 -12.25 N/A -7.22

    Citigroup 3-Mo. T-Bill 0.01 0.02 0.04 0.08 N/A 1.55

    Total Equities 9/30/00 2.53 3.68 3.66 17.12 6.87 3.54 6.59

    Citigroup 3-Mo. T-Bill 0.01 0.02 0.04 0.08 1.54 1.77

    3

  • 8/12/2019 GMO Quarterly Update Q2 2014

    5/62

    As of June 30, 2014

    GMO 2014

    GMO Benchmark-Free Allocation StrategyInception: 7/31/01; Benchmark: Consumer Price Index

    1Performance data quoted represents past performance and is not predictive of future performance. Returns are shown after the deduction of management fees,transaction costs and other expenses, but before custody charges, withholding taxes, and other indirect expenses. The returns assume the reinvestment of dividends andother income.

    The chart above shows the past performance of the Benchmark-Free Allocation Composite (the Composite). Prior to January 1, 2012, the accounts in the Compositeserved as the principal component of a broader real return strategy. Beginning January 1, 2012, accounts in the composite have been managed as a standalone investment.

    2The CPI (Consumer Price Index) for All Urban Consumers U.S. All Items is published monthly by the U.S. government as an indicator of changes in price levels (orinflation) paid by urban consumers for a representative basket of goods and services.

    3The groups indicated above represent exposures determined pursuant to proprietary methodologies and are subject to change over time.4The above information is based on a representative account in the Strategy selected because it has the fewest restrictions and best represents the implementation of the

    Strategy.5Std. Deviation is a measure of the volatility of a portfolios return. Sharpe Ratio is the return over the risk free rate per unit of risk. Drawdown is the largest negative

    cumulative portfolio return from peak to trough. Risk profile data is net.

    Performance Net of Fees1

    5-Year Risk Profi le5

    Bond Portfolio4

    Equity Regional Weights (%)4Group Exposures (%)3,4

    Equity Characteristics4

    Other Equity

    Absolute Return

    CashU.S. Equity

    Intl. Developed Equity

    Emerging Equity

    Fixed Income

    StrategyPrice/Earnings - Hist 1 Yr Wtd Med 15.5 x

    Price/Book - Hist 1 Yr Wtd Avg 1.6 x

    Return on Equity - Hist 1 Yr Med 11.1 %

    Market Cap - Weighted Median $Bil $40.1

    Dividend Yield - Hist 1 Yr Wtd Avg 3.1 %

    20.8

    27.8

    7.5

    1.5

    8.2

    34.3

    0 10 20 30 40

    Emerging

    Europe ex UK

    Japan

    Other International

    United Kingdom

    United States

    Strategy

    Bond Portfolio Duration 5.6 years

    Credit Ratings

    AAA 3.3% BB 10.5%

    AA 40.5% B 6.4%A 5.8%

  • 8/12/2019 GMO Quarterly Update Q2 2014

    6/62

  • 8/12/2019 GMO Quarterly Update Q2 2014

    7/62

    As of June 30, 2014

    GMO 2014

    GMO Global Allocation Absolute Return StrategyInception: 7/31/01; Benchmark: Consumer Price Index

    1Performance data quoted represents past performance and is not predictive of future performance. Returns are shown after the deduction of management fees,transaction costs and other expenses, but before custody charges, withholding taxes, and other indirect expenses. The returns assume the reinvestment of dividends andother income.

    2The GMO blended Global Asset Allocation Composite benchmark is comprised of a weighted average of account benchmarks; many of the account benchmarks consistof S&P 500, MSCI ACWI (MSCI Standard Index Series, net of withholding tax) and Barclays Aggregate or some like proxy for each market exposure they have. For eachunderlying account benchmark, the weighting of each market index will vary slightly. The index is internally blended by GMO and maintained on a monthly basis. MSCIdata may not be reproduced or used for any other purpose. MSCI provides no warranties, has not prepared or approved this report, and has no liability hereunder.

    3The above information is based on a representative account in the Strategy selected because it has the fewest restrictions and best represents the implementation of theStrategy.

    4Std. Deviation is a measure of the volatility of a portfolios return. Sharpe Ratio is the return over the risk free rate per unit of risk. Drawdown is the largest negativecumulative portfolio return from peak to trough. Risk profile data is net.

    Performance Net of Fees1

    5-Year Risk Profi le5

    Bond Portfolio4

    Equity Regional Weights (%)4Group Exposures (%)3,4

    Equity Characteristics4

    Other Equity

    Absolute Return

    CashU.S. Equity

    Intl. Developed Equity

    Emerging Equity

    Fixed Income

    StrategyStd. Deviation 5.28

    Sharpe Ratio 1.55

    Drawdown

    (3/31/10-6/30/10) -4.95

    20.6

    27.7

    7.6

    1.6

    8.2

    34.4

    0 10 20 30 40

    Emerging

    Europe ex UK

    Japan

    Other International

    United Kingdom

    United States

    Strategy

    StrategyPrice/Earnings - Hist 1 Yr Wtd Med 15.5 x

    Price/Book - Hist 1 Yr Wtd Avg 1.6 x

    Return on Equity - Hist 1 Yr Med 11.0 %

    Market Cap - Weighted Median $Bil $41.3

    Dividend Yield - Hist 1 Yr Wtd Avg 3.2 %

    Bond Portfolio Duration 2.4 years

    Credit Ratings

    AAA 1.4% BB 5.0%

    AA 72.3% B 3.2%A 2.6%

  • 8/12/2019 GMO Quarterly Update Q2 2014

    8/62

    As of June 30, 2014

    GMO 2014

    Quarterly Strategy Attribut ion

    Performance data quoted represents past performance and is not predictive of future performance. Returns are shown after the deduction of management fees,transaction costs and other expenses, but before custody charges, withholding taxes, and other indirect expenses. The returns assume the reinvestment of dividends andother income.

    GMO Global Allocation Absolute Return StrategyInception: 7/31/01; Benchmark: Consumer Price Index

    7

  • 8/12/2019 GMO Quarterly Update Q2 2014

    9/62

    As of June 30, 2014

    GMO 2014

    GMO Global Asset Allocation StrategyInception: 6/30/88; Benchmark: GMO Global Asset Allocation Index

    Performance Net of Fees1

    1Performance data quoted represents past performance and is not predictive of future performance. Returns are shown after the deduction of management fees,transaction costs and other expenses, but before custody charges, withholding taxes, and other indirect expenses. The returns assume the reinvestment of dividends andother income.

    2The GMO blended Global Asset Allocation Composite benchmark is comprised of a weighted average of account benchmarks; many of the account benchmarks consistof S&P 500, MSCI ACWI (MSCI Standard Index Series, net of withholding tax) and Barclays Aggregate or some like proxy for each market exposure they have. For eachunderlying account benchmark, the weighting of each market index will vary slightly. The index is internally blended by GMO and maintained on a monthly basis. MSCIdata may not be reproduced or used for any other purpose. MSCI provides no warranties, has not prepared or approved this report, and has no liability hereunder.

    3The groups indicated above represent exposures determined pursuant to proprietary methodologies and are subject to change over time.4The above information is based on a representative account in the Strategy selected because it has the fewest restrictions and best represents the implementation of the

    Strategy.5Alpha is a measure of risk-adjusted return; Beta is a measure of a portfolios sensitivity to the market; R2 is a measure of how well a portfolio tracks the market;

    Sharpe Ratio is the return over the risk free rate per unit of risk; Std. Deviation is a measure of the volatility of a portfolio. Risk profile data is net.

    Performance Net of Fees1

    5-Year Risk Profi le5

    Bond Portfolio4

    Equity Regional Weights (%)4Group Exposures (%)3,4

    Equity Characteristics4

    Other Equity

    Absolute Return

    CashU.S. Equity

    Intl. Developed Equity

    Emerging Equity

    Fixed Income

    Total Return (%) Average Annual Total Return (%)

    2Q YTD One Five Ten Since2014 2014 Year Year Year Inception

    Strategy 3.70 5.47 14.81 10.86 7.59 9.96Benchmark

    23.99 5.45 16.25 11.23 6.40 8.31

    Annu al Tota l Retu rn (%)

    2004 2005 2006 2007 2008 2009 2010 2011 2012 2013

    Strategy 13.55 9.06 12.30 7.94 -20.83 24.15 7.93 2.13 11.11 12.38

    Benchmark 10. 26 5. 99 13.41 9 .26 -27. 72 24. 14 11.05 -1 .80 12. 13 13. 60

    St r at eg y B en ch ma rkAlpha 1.45 0.00

    Beta 0.84 1.00

    R2

    0.95 1.00

    Sharpe Ratio 1.31 1.17

    Std. Deviation 8.22 9.57

    15.8

    31.4

    8.6

    1.8

    9.3

    33.1

    10.9

    16.8

    7.4

    8.3

    7.8

    48.9

    0 20 40 60

    Emerging

    Europe ex UK

    Japan

    Other International

    United Kingdom

    United States

    Strategy Benchmark

    St r at eg y Ben ch ma rkPrice/Earnings - Hist 1 Yr Wtd Med 15.5 x 18.4 x

    Price/Book - Hist 1 Yr Wtd Avg 1.6 x 2.1 x

    Return on Equity - Hist 1 Yr Med 11.0 % 14.3 %

    Market Cap - Weighted Median $Bil $41.3 $40.0

    Dividend Yield - Hist 1 Yr Wtd Avg 3.1 % 2.5 %

    Bond Portfolio Duration 2.4 years

    Credit Ratings

    AAA 1.8% BB 5.6%

    AA 68.1% B 3.3%A 3.2%

  • 8/12/2019 GMO Quarterly Update Q2 2014

    10/62

    As of June 30, 2014

    GMO 2014

    Quarterly Strategy Attribut ion

    Performance data quoted represents past performance and is not predictive of future performance. Returns are shown after the deduction of management fees,transaction costs and other expenses, but before custody charges, withholding taxes, and other indirect expenses. The returns assume the reinvestment of dividends andother income.

    GMO Global Asset Allocation StrategyInception: 6/30/88; Benchmark: GMO Global Asset Allocation Index

    9

  • 8/12/2019 GMO Quarterly Update Q2 2014

    11/62

    As of June 30, 2014

    GMO 2014

    GMO Real Return Global Balanced Asset Allocation StrategyInception: 6/30/04; Benchmark: Blended Benchmark

    1Performance data quoted represents past performance and is not predictive of future performance. Returns are shown after the deduction of management fees,transaction costs and other expenses, but before custody charges, withholding taxes, and other indirect expenses. The returns assume the reinvestment of dividends andother income.

    2The GMO blended Real Return Global Balanced Asset Allocation Composite benchmark is comprised of a weighted average of account benchmarks; many of the accountbenchmarks consist of MSCI World (MSCI Standard Index Series, net of withholding tax), Barclays Aggregate, and Citigroup 3-Month T-Bill or some like proxy for eachmarket exposure they have. For each underlying account benchmark, the weighting of each market index will vary slightly. The index is internally blended by GMO andmaintained on a monthly basis. MSCI data may not be reproduced or used for any other purpose. MSCI provides no warranties, has not prepared or approved thisreport, and has no liability hereunder.

    3The groups indicated above represent exposures determined pursuant to proprietary methodologies and are subject to change over time.4The above information is based on a representative account in the Strategy selected because it has the fewest restrictions and best represents the implementation of the

    Strategy.5Alpha is a measure of risk-adjusted return; Beta is a measure of a portfolios sensitivity to the market; R2 is a measure of how well a portfolio tracks the market;

    Sharpe Ratio is the return over the risk free rate per unit of risk; Std. Deviation is a measure of the volatility of a portfolio. Risk profile data is net.

    Performance Net of Fees1

    5-Year Risk Profi le5

    Bond Portfolio4

    Equity Regional Weights (%)4Group Exposures (%)3,4

    Equity Characteristics4

    Total Return (%) Average Annual Total Return (%)

    2Q YTD One Five Ten Since2014 2014 Year Year Year Inception

    Strategy 3.26 5.25 13.91 9.79 7.62 7.62Benchmark 2 3.31 4.53 14.96 10.08 5.95 5.95

    Annu al Tota l Retu rn (%)

    2004 2005 2006 2007 2008 2009 2010 2011 2012 2013

    Strategy 10.11 8.09 13.26 7.63 -11.36 13.02 5.00 3.16 10.65 13.68

    Benchmark 7.45 6.82 13.69 7.87 - 25.17 19.17 8.94 -1.76 10.42 14.95

    St r at eg y B en ch ma rkAlpha 1.87 0.00

    Beta 0.78 1.00

    R2

    0.90 1.00

    Sharpe Ratio 1.33 1.13

    Std. Deviation 7.29 8.82

    Other Equity

    Absolute Return

    CashU.S. Equity

    Intl. Developed Equity

    Emerging Equity

    Fixed Income

    0

    20

    40

    60

    80

    100 U.S. Quality, 11.9

    Europe Value, 19.0

    Other Int'l. Opportunistic Value, 1.1

    Emerging Markets, 7.3

    Cash & Cash Equiv., 1.0

    Debt Opportunities, 2.8

    Asset Allocation Bond, 15.0

    Risk Premium, 2.2

    Japan, 4.0

    U.S. Opportunistic Value, 3.6

    Multi Strategy, 29.0

    Emerging Country Debt, 3.1

    15.7

    31.3

    8.6

    1.8

    9.2

    33.4

    0.0

    18.9

    8.3

    9.3

    8.8

    54.8

    0 20 40 60

    Emerging

    Europe ex UK

    Japan

    Other International

    United Kingdom

    United States

    Strategy Benchmark

    St r at eg y Ben ch ma rkPrice/Earnings - Hist 1 Yr Wtd Med 15.5 x 18.7 x

    Price/Book - Hist 1 Yr Wtd Avg 1.6 x 2.2 x

    Return on Equity - Hist 1 Yr Med 11.0 % 14.5 %

    Market Cap - Weighted Median $Bil $42.0 $46.2

    Dividend Yield - Hist 1 Yr Wtd Avg 3.1 % 2.4 %

    Bond Portfolio Duration 2.5 years

    Credit Ratings

    AAA 1.3% BB 5.1%

    AA 73.0% B 3.3%A 2.4%

  • 8/12/2019 GMO Quarterly Update Q2 2014

    12/62

    As of June 30, 2014

    GMO 2014

    Quarterly Strategy Attribut ion

    Performance data quoted represents past performance and is not predictive of future performance. Returns are shown after the deduction of management fees,transaction costs and other expenses, but before custody charges, withholding taxes, and other indirect expenses. The returns assume the reinvestment of dividends andother income.

    GMO Real Return Global Balanced Asset Allocation StrategyInception: 6/30/04; Benchmark: Blended Benchmark

    11

  • 8/12/2019 GMO Quarterly Update Q2 2014

    13/62

    As of June 30, 2014

    GMO 2014

    GMO Tax-Managed Global Balanced StrategyInception: 12/31/02; Benchmark: GMO Tax-Managed Global Balanced Index

    1Performance data quoted represents past performance and is not predictive of future performance. Returns are shown after the deduction of management fees,transaction costs and other expenses, but before custody charges, withholding taxes, and other indirect expenses. The returns assume the reinvestment of dividends andother income.

    2The GMO Tax-Managed Global Balanced Index is an internally computed benchmark comprised of (i) 60% MSCI ACWI (All Country World Index) (MSCI standardIndex Series, net of withholding tax) and (ii) 40% Barclays Muni 7 Year (6-8) Index. MSCI data may not be reproduced or used for any other purpose. MSCI provides no

    warranties, has not prepared or approved this report, and has no liability hereunder.3The groups indicated above represent exposures determined pursuant to proprietary methodologies and are subject to change over time.4The above information is based on a representative account in the Strategy selected because it has the fewest restrictions and best represents the implementation of the

    Strategy.5Alpha is a measure of risk-adjusted return; Beta is a measure of a portfolios sensitivity to the market; R2 is a measure of how well a portfolio tracks the market;

    Sharpe Ratio is the return over the risk free rate per unit of risk; Std. Deviation is a measure of the volatility of a portfolio. Risk profile data is net.

    Performance Net of Fees1

    5-Year Risk Profi le5

    Equity Regional Weights (%)4Group Exposures (%)3,4

    Equity Characteristics4

    Other Equity

    Absolute Return

    CashU.S. Equity

    Intl. Developed Equity

    Emerging Equity

    Fixed Income

    Total Return (%) Average Annual Total Return (%)

    2Q YTD One Five Ten Since2014 2014 Year Year Year Inception

    Strategy 2.92 4.61 13.40 8.92 6.90 8.12Benchmark

    23.89 5.46 15.71 10.93 6.33 7.48

    Annu al Tota l Retu rn (%)

    2004 2005 2006 2007 2008 2009 2010 2011 2012 2013

    Strategy 12.73 9.91 12.08 7.16 -14.95 14.29 6.88 1.34 9.71 10.86

    Benchmark 10.02 5.91 12.95 7 .12 - 25.89 23.90 9.99 -0 .27 11.47 12.7 8

    St r at eg y B en ch ma rkAlpha -0.02 0.00

    Beta 0.82 1.00

    R2

    0.96 1.00

    Sharpe Ratio 1.18 1.21

    Std. Deviation 7.50 9.00

    0

    20

    40

    60

    80

    100 U.S. Quality, 13.1

    Europe Value, 19.9

    Other Int'l. Opportunistic Value, 1.2

    Emerging Markets, 7.1

    Cash & Cash Equiv., 2.8

    Municipal Bonds, 32.0

    Emerging Country Debt, 2.3Risk Premium, 2.1

    Japan, 3.5

    U.S. Opportunistic Value, 2.6

    Multi-Strategy, 13.3

    U.S. Small, 0.115.2

    31.9

    7.3

    2.3

    10.1

    33.2

    10.9

    16.8

    7.4

    8.3

    7.8

    48.9

    0 20 40 60

    Emerging

    Europe ex UK

    Japan

    Other International

    United Kingdom

    United States

    Strategy Benchmark

    St r at eg y Ben ch ma rkPrice/Earnings - Hist 1 Yr Wtd Med 16.0 x 16.0 x

    Price/Cash Flow - Hist 1 Yr Wtd Med 1.7 x 1.7 x

    Price/Book - Hist 1 Yr Wtd Avg 1.7 x 1.7 x

    Return on Equity - Hist 1 Yr Med 13.1 % 13.1 %

    Market Cap - Weighted Median $Bil $41.3 $41.3

    Dividend Yield - Hist 1 Yr Wtd Avg 3.0 % 3.0 %

    12

  • 8/12/2019 GMO Quarterly Update Q2 2014

    14/62

    As of June 30, 2014

    GMO 2014

    Quarterly Strategy Attribut ion

    Performance data quoted represents past performance and is not predictive of future performance. Returns are shown after the deduction of management fees,transaction costs and other expenses, but before custody charges, withholding taxes, and other indirect expenses. The returns assume the reinvestment of dividends andother income.

    GMO Tax-Managed Global Balanced StrategyInception: 12/31/02; Benchmark: GMO Tax-Managed Global Balanced Index

    13

  • 8/12/2019 GMO Quarterly Update Q2 2014

    15/62

    As of June 30, 2014

    GMO 2014

    5-Year Risk Profi le5

    Top Holdings4,6

    Top Country Weights (%)4Group Exposures (%)3,4

    Characteristics4

    Performance Net of Fees1

    GMO Global All Country Equity Allocation StrategyInception: 12/31/93; Benchmark: MSCI All Country World Index

    1Performance data quoted represents past performance and is not predictive of future performance. Returns are shown after the deduction of management fees,transaction costs and other expenses, but before custody charges, withholding taxes, and other indirect expenses. The returns assume the reinvestment of dividends andother income.

    2The GMO blended Global All Country Equity Allocation Composite benchmark is comprised of a weighted average of account benchmarks; many of the accountbenchmarks consist of MSCI ACWI (All Country World Index) (MSCI standard Index Series, net of withholding tax) or some like proxy for each market exposure theyhave. For each underlying account benchmark, the weighting of each market index will vary slightly. The index is internally blended by GMO and maintained on amonthly basis. MSCI data may not be reproduced or used for any other purpose. MSCI provides no warranties, has not prepared or approved this report, and has noliability hereunder.

    3The groups indicated above represent exposures determined pursuant to proprietary methodologies and are subject to change over time.4The above information is based on a representative account in the Strategy selected because it has the fewest restrictions and best represents the implementation of the

    Strategy.5Alpha is a measure of risk-adjusted return; Beta is a measure of a portfolios sensitivity to the market; R2 is a measure of how well a portfolio tracks the market;

    Sharpe Ratio is the return over the risk free rate per unit of risk; Std. Deviation is a measure of the volatility of a portfolio. Risk profile data is net.6Portfolio holdings are subject to change and should not be considered a recommendation to buy individual securities.

    Total Return (%) Average Annual Total Return (%)

    2Q YTD One Five Ten Since2014 2014 Year Year Year Inception

    Strategy 4.91 7.06 22.57 14.13 8.79 9.58Benchmark 2 5.04 6.19 23.10 14.62 7.35 7.73

    An nu al To ta l Return (%)

    2004 2005 2006 2007 2008 2009 2010 2011 2012 2013

    Strategy 17.62 12.51 18.87 11.12 -31.41 24.19 10.12 -1.29 14.74 21.33

    Benchmark 14.86 9.95 20.34 10.38 -41.82 34.45 12.94 -6.87 16.34 23.46

    St ra teg y B en ch ma r k

    Alpha 1.29 0.00

    Beta 0.88 1.00

    R2

    0.97 1.00

    Sharpe Ratio 1.06 0.98

    Std. Deviation 13.25 14.83

    0

    20

    40

    60

    80

    100

    U.S. Quality, 26.8

    Europe Value, 39.3

    Other Int'l. Opportunistic Value, 2.2Emerging Markets, 12.8Cash & Cash Equiv., 2.3

    Japan, 8.4

    U.S. Opportunistic Value, 8.2

    U.S. Equity

    Intl. Developed Equity

    Emerging Equity

    Cash

    St ra teg y Ben ch ma rk

    Price/Earnings - Hist 1 Yr Wtd Med 15.6 x 18.4 x

    Price/Book - Hist 1 Yr Wtd Avg 1.6 x 2.1 x

    Return on Equity - Hist 1 Yr Med 11.2 % 14.3 %

    Market Cap - Weighted Median $Bil $46.6 $40.0

    Dividend Yield - Hist 1 Yr Wtd Avg 3.1 % 2.5 %

    ompany oun ry ec or o qu y

    Total S.A. France Energy 2.8

    Royal Dutch Shell PLC United Kingdom Energy 2.4

    Oracle Corp. United States Information Technology 1.9

    BP PLC United Kingdom Energy 1.9

    Philip Morris International United States Consumer Staples 1.8

    Total 10.8

    35.4

    9.7

    9.0

    8.3

    8.2

    48.9

    3.7

    7.8

    7.4

    3.4

    0 20 40 60

    United States

    France

    United Kingdom

    Japan

    Germany

    Strategy Benchmark

    14

  • 8/12/2019 GMO Quarterly Update Q2 2014

    16/62

    As of June 30, 2014

    GMO 2014

    Quarterly Strategy Attribut ion

    Performance data quoted represents past performance and is not predictive of future performance. Returns are shown after the deduction of management fees,transaction costs and other expenses, but before custody charges, withholding taxes, and other indirect expenses. The returns assume the reinvestment of dividends andother income.

    GMO Global All Country Equity Allocation StrategyInception: 12/31/93; Benchmark: MSCI All Country World Index

    15

  • 8/12/2019 GMO Quarterly Update Q2 2014

    17/62

    As of June 30, 2014

    GMO 2014

    5-Year Risk Profi le5

    Top Holdings4,6

    Top Country Weights (%)4Group Exposures (%)3,4

    Characteristics4

    Performance Net of Fees1

    1Performance data quoted represents past performance and is not predictive of future performance. Returns are shown after the deduction of management fees,transaction costs and other expenses, but before custody charges, withholding taxes, and other indirect expenses. The returns assume the reinvestment of dividends andother income.

    2 The GMO blended Global Developed Equity Allocation Composite benchmark is comprised of a weighted average of account benchmarks; many of the accountbenchmarks consist of MSCI World (MSCI Standard Index Series, net of withholding tax) or some like proxy for each market exposure they have. For each underlyingaccount benchmark, the weighting of each market index will vary slightly. The index is internally blended by GMO and maintained on a monthly basis. MSCI data maynot be reproduced or used for any other purpose. MSCI provides no warranties, has not prepared or approved this report, and has no liability hereunder.

    3The groups indicated above represent exposures determined pursuant to proprietary methodologies and are subject to change over time.4The above information is based on a representative account in the Strategy selected because it has the fewest restrictions and best represents the implementation of the

    Strategy.5Alpha is a measure of risk-adjusted return; Beta is a measure of a portfolios sensitivity to the market; R2 is a measure of how well a portfolio tracks the market;

    Sharpe Ratio is the return over the risk free rate per unit of risk; Std. Deviation is a measure of the volatility of a portfolio. Risk profile data is net.6Portfolio holdings are subject to change and should not be considered a recommendation to buy individual securities.

    GMO Global Developed Equity Allocation StrategyInception: 3/31/87; Benchmark: MSCI World Index

    Total Return (%) Average Annual Total Return (%)

    2Q YTD One Five Ten Since2014 2014 Year Year Year Inception

    Strategy 4.79 7.58 24.57 14.87 8.44 9.79Benchmark 2 4.86 6.18 24.05 15.00 7.13 7.64

    An nu al To ta l Return (%)

    2004 2005 2006 2007 2008 2009 2010 2011 2012 2013

    Strategy 17.36 12.26 20.22 9.69 -33.19 20.55 9.25 -0.40 14.14 25.82

    Benchmark 13.64 9.42 20.05 9.02 -40.70 29.97 11.77 -5.52 15.84 26.68

    St ra teg y B en ch ma r k

    Alpha 1.51 0.00

    Beta 0.89 1.00

    R2

    0.97 1.00

    Sharpe Ratio 1.12 1.02

    Std. Deviation 13.19 14.58

    0

    20

    40

    60

    80

    100

    U.S. Quality, 26.6

    Europe Value, 42.0

    Other Int'l. Opportunistic Value, 2.4Emerging Markets, 9.6Cash & Cash Equiv., 2.3

    Japan, 9.0

    U.S. Opportunistic Value, 8.2

    U.S. Equity

    Intl. Developed Equity

    Emerging Equity

    Cash

    St ra teg y Ben ch ma rk

    Price/Earnings - Hist 1 Yr Wtd Med 15.7 x 18.7 x

    Price/Book - Hist 1 Yr Wtd Avg 1.6 x 2.2 x

    Return on Equity - Hist 1 Yr Med 11.1 % 14.5 %

    Market Cap - Weighted Median $Bil $46.7 $46.2

    Dividend Yield - Hist 1 Yr Wtd Avg 3.1 % 2.4 %

    Company Country Sector % of Equi ty

    Total S.A. France Energy 3.0

    Royal Dutch Shell PLC United Kingdom Energy 2.5

    BP PLC United Kingdom Energy 2.0

    Oracle Corp. United States Information Technology 1.9

    Philip Morris International United States Consumer Staples 1.8

    Total 11.2

    35.1

    10.4

    9.6

    8.9

    8.8

    54.8

    4.1

    8.8

    8.3

    3.8

    0 20 40 60

    United States

    France

    United Kingdom

    Japan

    Germany

    Strategy Benchmark

    16

  • 8/12/2019 GMO Quarterly Update Q2 2014

    18/62

    As of June 30, 2014

    GMO 2014

    Quarterly Strategy Attribut ion

    Performance data quoted represents past performance and is not predictive of future performance. Returns are shown after the deduction of management fees,transaction costs and other expenses, but before custody charges, withholding taxes, and other indirect expenses. The returns assume the reinvestment of dividends andother income.

    GMO Global Developed Equity Allocation StrategyInception: 3/31/87; Benchmark: MSCI World Index

    17

  • 8/12/2019 GMO Quarterly Update Q2 2014

    19/62

    As of June 30, 2014

    GMO 2014

    GMO Global Focused Equity StrategyInception: 12/31/11

    Performance Net of Fees1 Top Ten Holdings2,5

    Sector Weights5

    GICS Sectors

    Region Weights 5

    1Performance data quoted represents past performance and is not predictive of future performance. Returns are shown after the deduction of management fees,transaction costs and other expenses, but before custody charges, withholding taxes, and other indirect expenses. The returns assume the reinvestment of dividends andother income.

    2Portfolio holdings are percent of equity. They are subject to change and should not be considered a recommendation to buy individual securities.3The Global Focused Equity Strategy does not have a benchmark. The Strategy has been compared to the MSCI All Country World Index in an effort to compare and

    contrast the Strategy versus a broad global equity index. The MSCI ACWI (All Country World) Index (MSCI Standard Index Series, net of withholding tax) is anindependently maintained and widely published index comprised of global developed and emerging markets. MSCI data may not be reproduced or used for any otherpurpose. MSCI provides no warranties, has not prepared or approved this report, and has no liability hereunder.

    4Alpha is a measure of risk-adjusted return; Beta is a measure of a portfolios sensitivity to the market; R2 is a measure of how well a portfolio tracks the market;Sharpe Ratio is the return over the risk free rate per unit of risk; Std. Deviation is a measure of the volatility of a portfolio. Risk profile data is net.

    5The above information is based on a representative account in the Strategy selected because it has the fewest restrictions and best represents the implementation of theStrategy.

    Risk Profile Since 12/31/114 Characteristics5

    Total Return (%) Average Annual Total Return (%)

    2Q YTD One Five Ten Since2014 2014 Year Year Year Inception

    Strategy 5.38 6.15 32.21 N/A N/A 22.72Benchmark 3 5.04 6.18 22.95 N/A N/A 18.05

    An nu al To ta l Retur n (%)

    2012 2013

    Str ategy 19.71 31.29

    Benchmark 16.13 22.80

    St ra teg y Ben ch ma rk

    Alpha 0.35 0.00

    Beta 1.24 1.00

    R2 0.85 1.00Sharpe Ratio 1.56 1.67

    Std. Deviation 14.54 10.81

    Samsung Elect ronics Co. 3 .6%

    ITT Corp 2.3%

    Comcast Corp. 2.3%

    China Unicom Ltd. 2.3%

    TriMas Corp. 2.3%

    National-Oilwell Inc. 2.2%

    Methanex Corp. 2.2%

    Capital Product Partners LP 2.2%

    MagnaChip Semiconductor 2.2%

    KapStone Paper & Pack. 2.2%

    Total 23.8%

    St ra teg y Ben ch ma rk

    Price/Earnings - Hist 1 Yr Wtd Med 16.0 x 18.4 x

    Pri ce/Cash Flow- Hist 1 Yr Wtd Med 11.0 x 12.8 x

    Price/Book - Hist 1 Yr Wtd Avg 1.7 x 2.1 x

    Dividend Yield - Hist 1 Yr Wtd Avg 1.9 % 2.5 %

    Underweight/Overweighteg on ga ns enc mar

    Australia/New Zealand

    Canada

    Emerging

    Europe ex UK

    Japan

    Southeast Asia

    United Kingdom

    United States

    Cash + Unrealized G/L

    2.2

    0.0

    -0.2

    -1.0

    -0.2

    0.6

    -1.0

    -3.3

    2.6

    -4 -2 0 2 4

    Underweight/Overweightec or ga ns enc mar ra egy enc mar

    Consumer Discretionary 15.7 % 11.6 %Consumer Staples 1.7 9.6Energy 14.3 10.2Financials 17.0 21.3Health Care 8.1 10.6Industrials 11.8 10.7Information Technology 15.4 12.8Materials 11.7 6.1Telecom. Serv ices 2.3 3.8Utilities 1.9 3.4-1.5

    -1.5

    5.6

    2.6

    1.1

    -2.5

    -4.3

    4.1

    -7.9

    4.1

    -10 -5 0 5 10

    18

  • 8/12/2019 GMO Quarterly Update Q2 2014

    20/62

    As of June 30, 2014

    GMO 2014

    Quarterly Strategy Attribut ion

    Performance data quoted represents past performance and is not predictive of future performance. Returns are shown after the deduction of management fees,transaction costs and other expenses, but before custody charges, withholding taxes, and other indirect expenses. The returns assume the reinvestment of dividends andother income.

    GMO Global Focused Equity StrategyInception: 12/31/11

    The Global Focused Equity Strategy rose 5.4% net of fees for the quarter. The strategys reference benchmark, MSCI All CountryWorld index gained 5.0%.

    Large positive contributions came from holdings in Suncor Energy in Canada and American Airlines in the United States. Suncor,Canada's largest oil and gas company, outperformed over the quarter as the oil price rose. Concerns about increasing violence in Iraq

    have boosted the Energy sector as the higher oil price has increased profits and shipment bottlenecks for the Canadian companieshave been addressed. American Airlines (AAL) continues to be a significant beneficiary of industry-wide improvements. In particular,higher load factors, better base and ancillary pricing, and capacity discipline all drive margin expansion and earnings growth in theintermediate term. As the last legacy airline to merge, AAL has company-specific catalysts, including cost synergies and re-fleeting fuelinefficient aircraft, but also has committed to announcing a plan for reducing elevated cash levels through a significant sharerepurchase plan.

    The largest detractors from performance were Topps Tiles in the United Kingdom and United Continental in the United States.Topps Tiles fell due to investors selling interest-rate-sensitive stocks in anticipation of imminent rate rises as U.K. economic datacontinued to surprise on the upside. We view the de-rating as significantly overdone and think the market is underestimating therecovery potential in stocks such as Topps given the depths of the recent recession. As a consequence, we recently added to theposition. For United, despite poor execution in the wake of its merger with Continental Airlines, the company still offers the mostrobust earnings recovery in the industry, as it is poised to nearly double earnings from 2014 to 2016. It is true that it has squandered

    favorable industry conditions, and though it has the same revenue base as Delta, it is half as profitable. We believe that UnitedContinental is poised to close this margin gap in the coming years. The company has announced over $2 billion of internal costopportunities that it will complete in the next three years. It has significant opportunities to improve its yield management results aswell as its route optimization and scheduling system. The severe weather in the first quarter and subsequent earnings miss causedinvestors to lose confidence in this management team, but we believe that the stock offers significant upside with any earningsrecovery.

    19

  • 8/12/2019 GMO Quarterly Update Q2 2014

    21/62

    As of June 30, 2014

    GMO 2014

    GMO Quality StrategyInception: 2/29/04; Benchmark: S&P 500 Index

    GICS Sectors

    5-Year Risk Profi le4

    Top Holdings3,5

    Sector Weights (%)3Region Weights (%)3

    Characteristics3

    Performance Net of Fees1

    1Performance data quoted represents past performance and is not predictive of future performance. Returns are shown after the deduction of management fees,transaction costs and other expenses, but before custody charges, withholding taxes, and other indirect expenses. The returns assume the reinvestment of dividends andother income.

    2The S&P 500 Index is an independently maintained and widely published index comprised of U.S. large capitalization stocks. S&P does not guarantee the accuracyadequacy, completeness or availability of any data or information and is not responsible for any errors or omissions from the use of such data or information.Reproduction of the data or information in any form is prohibited except with the prior written permission of S&P or its third party licensors.

    3The above information is based on a representative account in the Strategy selected because it has the fewest restrictions and best represents the implementation of theStrategy.

    4Alpha is a measure of risk-adjusted return; Beta is a measure of a portfolios sensitivity to the market; R2 is a measure of how well a portfolio tracks the market;Sharpe Ratio is the return over the risk free rate per unit of risk; Std. Deviation is a measure of the volatility of a portfolio. Risk profile data is net.

    5Portfolio holdings are subject to change and should not be considered a recommendation to buy individual securities.

    An nu al To ta l Return (%)

    2004 2005 2006 2007 2008 2009 2010 2011 2012 2013

    Strategy 3.54 -0.79 12.69 6.04 -24.08 19.89 5.48 11.84 11.81 25.47

    Benchmark 7.39 4.91 15.80 5.49 -37.00 26.46 15.06 2.11 16.00 32.39

    St ra teg y B en ch ma r k

    Alpha 1.33 0.00

    Beta 0.77 1.00

    R2

    0.86 1.00

    Sharpe Ratio 1.43 1.41

    Std. Deviation 11.01 13.29

    10.2

    88.8

    1.0

    0.0

    100.0

    0.0

    0 20 40 60 80 100

    Non U.S.

    U.S.

    Cash

    Strategy Benchmark

    5.9

    22.8

    5.3

    0.0

    23.5

    6.7

    33.7

    1.0

    1.2

    0.0

    11.9

    9.5

    10.9

    16.113.2

    10.5

    18.9

    3.5

    2.4

    3.2

    0 10 20 30 4

    Consumer Discretionary

    Consumer Staples

    Energy

    Financials

    Health Care

    Industrials

    Information Technology

    Materials

    Telecommunication Services

    Utilities

    Strategy Benchmark

    St r at eg y B en ch ma rk

    Price/Earnings - Hist 1 Yr Wtd Med 19.6 x 19.5 x

    Price/Book - Hist 1 Yr Wtd Avg 3.9 x 2.7 x

    Return on Equity - Hist 1 Yr Med 20.1 % 17.4 %

    Market Cap - Weighted Median $Bil $132.9 $68.3

    Debt/Equity Wtd Med 0.5 x 0.8 x

    Dividend Yield - Hist 1 Yr Wtd Avg 2.2 % 2.0 %

    Company Sector % of Equi ty

    Microsoft Corp. Information Technology 5.0

    Philip Morris Int'l. Inc. Consumer Staples 4.8Oracle Corp. Information Technology 4.6

    Johnson & Johnson Health Care 4.4

    Apple Inc. Information Technology 4.3

    Total 23.1

    Total Return (%) Average Annual Total Return (%)

    2Q YTD One Five Ten Since2014 2014 Year Year Year Inception

    Strategy 3.69 5.77 17.59 15.85 6.89 6.71Benchmark 2 5.23 7.14 24.61 18.83 7.78 7.54

    20

  • 8/12/2019 GMO Quarterly Update Q2 2014

    22/62

    As of June 30, 2014

    GMO 2014

    Quarterly Strategy Attribut ion

    Performance data quoted represents past performance and is not predictive of future performance. Returns are shown after the deduction of management fees,transaction costs and other expenses, but before custody charges, withholding taxes, and other indirect expenses. The returns assume the reinvestment of dividends andother income.

    GMO Quality StrategyInception: 2/29/04; Benchmark: S&P 500 Index

    21

  • 8/12/2019 GMO Quarterly Update Q2 2014

    23/62

    As of June 30, 2014

    GMO 2014

    GMO Resources StrategyInception: 12/31/11; Benchmark: MSCI ACWI Commodity Producers Index

    Performance Net of Fees1

    Top Country Weights (%)3

    Risk Profile Since 12/31/114

    Top Holdings3,5

    Sector Weights (%)3

    Characteristics3

    1Performance data quoted represents past performance and is not predictive of future performance. Returns are shown after the deduction of management fees,transaction costs and other expenses, but before custody charges, withholding taxes, and other indirect expenses. The returns assume the reinvestment of dividends andother income.

    2The MSCI ACWI (All Country World) Commodity Producers Index (MSCI Standard Index Series, net of withholding tax) is an independently maintained and widelypublished index comprised of listed large and mid capitalization commodity producers within the global developed and emerging markets. MSCI data may not bereproduced or used for any other purpose. MSCI provides no warranties, has not prepared or approved this report, and has no liability hereunder.

    3The above information is based on a representative account in the Strategy selected because it has the fewest restrictions and best represents the implementation of theStrategy.

    4Alpha is a measure of risk-adjusted return; Beta is a measure of a portfolios sensitivity to the market; R2 is a measure of how well a portfolio tracks the market;Sharpe Ratio is the return over the risk free rate per unit of risk; Std. Deviation is a measure of the volatility of a portfolio. Risk profile data is net.

    5Portfolio holdings are subject to change and should not be considered a recommendation to buy individual securities.

    An nu al Tota l Retu rn (%)

    2012 2013

    Strategy 9.23 4.39

    Benchmark 1.96 3.31

    St r at eg y B en ch ma r k

    Alpha 4.09 0.00

    Beta 1.05 1.00

    R2

    0.96 1.00

    Sharpe Ratio 0.64 0.39

    Std. Deviation 16.01 14.93

    17.5

    12.3

    11.9

    10.1

    8.6

    38.8

    18.5

    1.8

    3.5

    1.2

    0 10 20 30 40

    United States

    United Kingdom

    Japan

    Russia

    Norway

    Strategy Benchmark

    0.0

    1.7

    76.0

    0.0

    0.010.2

    0.0

    6.8

    0.0

    5.3

    0.0

    1.5

    70.5

    0.0

    0.0

    0.0

    0.0

    28.0

    0.0

    0.0

    0 20 40 60 80

    Consumer Discretionary

    Consumer Staples

    Energy

    Financials

    Health Care

    Industrials

    Information Technology

    Materials

    Telecommunication Services

    Utilities

    Strategy Benchmark

    GICS Sectors

    Strategy Benchmark

    Price/Earnings - Hist 1 Yr Wtd Med 12.2 x 14.2 x

    Earni ngs/Share - Forecast LT Median Gr owth Rate 6.0 x 7.0 x

    Return on Equity - Hist 1 Yr Med 10.5 % 11.6 %

    Market Cap - Weighted Median $Bil $34.3 $59.1

    Dividend Yield - Hist 1 Yr Wtd Avg 3.9 % 3.0 %

    Company Country Sector % of Equi ty

    Petroleo Brasileiro S/A Brazil Energy 5.1

    Chevron Corp. United States Energy 5.0

    BP PLC United Kingdom Energy 5.0Total S.A. France Energy 5.0

    CNOOC Ltd. China Energy 4.9

    Total 25.0

    Total Return (%) Average Annual Total Return (%)

    2Q YTD One Five Ten Since2014 2014 Year Year Year Inception

    Strategy 10.58 11.86 29.14 N/A N/A 10.22Benchmark 2 9.28 9.39 24.97 N/A N/A 5.83

    22

  • 8/12/2019 GMO Quarterly Update Q2 2014

    24/62

    As of June 30, 2014

    GMO 2014

    Quarterly Strategy Attribut ion

    Performance data quoted represents past performance and is not predictive of future performance. Returns are shown after the deduction of management fees,transaction costs and other expenses, but before custody charges, withholding taxes, and other indirect expenses. The returns assume the reinvestment of dividends andother income.

    GMO Resources StrategyInception: 12/31/11; Benchmark: MSCI ACWI Commodity Producers Index

    23

  • 8/12/2019 GMO Quarterly Update Q2 2014

    25/62

    As of June 30, 2014

    GMO 2014

    GMO International All Country Equity Allocation StrategyInception: 2/28/94; Benchmark: MSCI All Country World ex USA Index

    1Performance data quoted represents past performance and is not predictive of future performance. Returns are shown after the deduction of management fees,transaction costs and other expenses, but before custody charges, withholding taxes, and other indirect expenses. The returns assume the reinvestment of dividends andother income.

    2The GMO blended International All Country Equity Allocation Composite benchmark is comprised of a weighted average of account benchmarks; many of the accountbenchmarks consist of MSCI ACWI (All Country World Index) ex USA (MSCI Standard Index Series, net of withholding tax) or some like proxy for each marketexposure they have. For each underlying account benchmark, the weighting of each market index will vary slightly. The index is internally blended by GMO andmaintained on a monthly basis. MSCI data may not be reproduced or used for any other purpose. MSCI provides no warranties, has not prepared or approved thisreport, and has no liability hereunder.

    3The groups indicated above represent exposures determined pursuant to proprietary methodologies and are subject to change over time.4The above information is based on a representative account in the Strategy selected because it has the fewest restrictions and best represents the implementation of the

    Strategy.5Alpha is a measure of risk-adjusted return; Beta is a measure of a portfolios sensitivity to the market; R2 is a measure of how well a portfolio tracks the market;

    Sharpe Ratio is the return over the risk free rate per unit of risk; Standard Deviation is a measure of the volatility of a portfolio. Risk profile data is net.6Portfolio holdings are subject to change and should not be considered a recommendation to buy individual securities.

    Performance Net of Fees1

    5-Year Risk Profi le5

    Top Holdings4,6

    Top Country Weights (%)4Group Exposures (%)3,4

    Total Return (%) Average Annual Total Return (%)

    2Q YTD One Five Ten Since2014 2014 Year Year Year Inception

    Strategy 5.91 7.89 26.40 12.16 8.72 8.20Benchmark 2 5.01 5.54 21.78 11.07 7.69 6.17

    An nua l To ta l Retur n (%)

    2004 2005 2006 2007 2008 2009 2010 2011 2012 2013

    Strategy 24.06 19.03 25.91 17.39 -40.96 27.77 12.74 -11.31 16.82 16.71

    Benchmark 21.11 16.71 26.94 16.08 -45.26 40.16 10.82 -13.63 16.90 15.47

    U.S. Equity

    Intl. Developed Equity

    Emerging Equity

    Cash

    Characteristics4

    Company Country Sector % of Equi ty

    Total S.A. France Energy 4.2

    Royal Dutch Shell PLC United Kingdom Energy 3.6

    BP PLC United Kingdom Energy 2.9

    DaimlerChrysler AG Germany Consumer Discretionary 2.0

    Telefonica S.A. Spain Telecommunication Services 2.0

    Total 14.7

    St ra teg y Ben ch ma rk

    Price/Earnings - Hist 1 Yr Wtd Med 14.2 x 16.9 x

    Price/Book - Hist 1 Yr Wtd Avg 1.2 x 1.7 x

    Return on Equity - Hist 1 Yr Med 9.4 % 11.7 %

    Market Cap - Weighted Median $Bil $27.9 $26.1

    Dividend Yield - Hist 1 Yr Wtd Avg 3.7 % 2.9 %

    St r a t eg y B en ch ma rk

    Alpha 1.41 0.00

    Beta 0.97 1.00

    R2

    0.98 1.00

    Sharpe Ratio 0.73 0.66

    Std. Deviation 16.48 16.76

    0

    20

    40

    60

    80

    100 U.S. Quality, 0.2

    Europe Value, 59.1

    Other Int'l. Opportunistic Value, 3.3

    Emerging Markets, 22.4

    Cash & Cash Equiv., 2.4

    Japan, 12.6

    14.6

    13.5

    12.5

    12.4

    4.7

    7.2

    15.3

    14.4

    6.6

    1.9

    0 5 10 15 20

    France

    United Kingdom

    Japan

    Germany

    Italy

    Strategy Benchmark

    24

  • 8/12/2019 GMO Quarterly Update Q2 2014

    26/62

    As of June 30, 2014

    GMO 2014

    Quarterly Strategy Attribut ion

    Performance data quoted represents past performance and is not predictive of future performance. Returns are shown after the deduction of management fees,transaction costs and other expenses, but before custody charges, withholding taxes, and other indirect expenses. The returns assume the reinvestment of dividends andother income.

    GMO International All Country Equity Allocation StrategyInception: 2/28/94; Benchmark: MSCI All Country World ex USA Index

    25

  • 8/12/2019 GMO Quarterly Update Q2 2014

    27/62

    As of June 30, 2014

    GMO 2014

    GMO International Developed Equity Allocation StrategyInception: 11/30/91; Benchmark: MSCI EAFE Index

    Performance Net of Fees1

    Group Exposures (%)3

    Total Return (%) Average Annual Total Return (%)

    2Q YTD One Five Ten Since2014 2014 Year Year Year Inception

    Strategy 5.54 9.02 30.16 13.28 8.31 8.96Benchmark 2 4.09 4.78 23.57 11.82 7.20 6.79

    An nua l To ta l Retur n (%)

    2004 2005 2006 2007 2008 2009 2010 2011 2012 2013

    Strategy 24.89 15.56 25.50 12.69 -38.39 19.84 10.58 -9.45 17.09 24.13

    Benchmark 21.17 14.41 26.62 11.58 -43.33 32.16 7.93 -12.14 17.32 22.78

    5-Year Risk Profi le5

    Top Holdings4,6

    Top Country Weights (%)4

    Characteristics4

    St r a t eg y B en ch ma rk

    Alpha 2.19 0.00

    Beta 0.94 1.00

    R2

    0.97 1.00

    Sharpe Ratio 0.82 0.69

    Std. Deviation 16.11 16.93

    ompany oun ry ec or o qu y

    Total S.A. France Energy 4.9

    Royal Dutch Shell PLC United Kingdom Energy 4.2

    BP PLC United Kingdom Energy 3.4

    DaimlerChrysler AG Germany Consumer Discretionary 2.4

    Telefonica S.A. Spain Telecommunication Services 2.4

    Total 17.3

    St ra teg y Ben ch ma rk

    Price/Earnings - Hist 1 Yr Wtd Med 14.2 x 17.5 x

    Price/Book - Hist 1 Yr Wtd Avg 1.3 x 1.7 x

    Return on Equity - Hist 1 Yr Med 9.7 % 11.2 %

    Market Cap - Weighted Median $Bil $29.5 $35.4

    Dividend Yield - Hist 1 Yr Wtd Avg 3.6 % 3.0 %

    1Performance data quoted represents past performance and is not predictive of future performance. Returns are shown after the deduction of management fees,transaction costs and other expenses, but before custody charges, withholding taxes, and other indirect expenses. The returns assume the reinvestment of dividends andother income.

    2The GMO blended International Developed Equity Allocation Composite benchmark is comprised of a weighted average of account benchmarks; many of the accountbenchmarks consist of MSCI EAFE (MSCI Standard Index Series, net of withholding tax) or some like proxy for each market exposure they have. For each underlyingaccount benchmark, the weighting of each market index will vary slightly. The index is internally blended by GMO and maintained on a monthly basis. MSCI data maynot be reproduced or used for any other purpose. MSCI provides no warranties, has not prepared or approved this report, and has no liability hereunder.

    3The groups indicated above represent exposures determined pursuant to proprietary methodologies and are subject to change over time.4The above information is based on a representative account in the Strategy selected because it has the fewest restrictions and best represents the implementation of the

    Strategy.5Alpha is a measure of risk-adjusted return; Beta is a measure of a portfolios sensitivity to the market; R2 is a measure of how well a portfolio tracks the market;

    Sharpe Ratio is the return over the risk free rate per unit of risk; Standard Deviation is a measure of the volatility of a portfolio. Risk profile data is net.6Portfolio holdings are subject to change and should not be considered a recommendation to buy individual securities.

    U.S. Equity

    Intl. Developed Equity

    Emerging Equity

    Cash

    0

    20

    40

    60

    80

    100 U.S. Quality, 0.1

    Europe Value, 69.0

    Other Int'l. Opportunistic Value, 3.8

    Emerging Markets, 9.6Cash & Cash Equiv., 2.7

    Japan, 14.8

    17.2

    15.9

    14.8

    14.6

    5.5

    10.1

    21.4

    20.2

    9.3

    2.6

    0 5 10 15 20 25

    France

    United Kingdom

    Japan

    Germany

    Italy

    Strategy Benchmark

    26

  • 8/12/2019 GMO Quarterly Update Q2 2014

    28/62

    As of June 30, 2014

    GMO 2014

    Quarterly Strategy Attribut ion

    Performance data quoted represents past performance and is not predictive of future performance. Returns are shown after the deduction of management fees,transaction costs and other expenses, but before custody charges, withholding taxes, and other indirect expenses. The returns assume the reinvestment of dividends andother income.

    GMO International Developed Equity Allocation StrategyInception: 11/30/91; Benchmark: MSCI EAFE Index

    27

  • 8/12/2019 GMO Quarterly Update Q2 2014

    29/62

    As of June 30, 2014

    GMO 2014

    GMO International Equity StrategyInception: 3/31/87; Benchmark: MSCI EAFE Index

    Performance Net of Fees1

    (The GMO International Equity Strategy was formerly known as the GMO International Intrinsic Value Strategy. GMO renamed the Strategy on June 30,

    2014.)

    Group Exposures (%)3

    5-Year Risk Profi le5

    Top Holdings4,6

    Top Country Weights (%)4

    Characteristics4

    1Performance data quoted represents past performance and is not predictive of future performance. Returns are shown after the deduction of management fees,transaction costs and other expenses, but before custody charges, withholding taxes, and other indirect expenses. The returns assume the reinvestment of dividends andother income.

    2The MSCI EAFE (Europe, Australasia, and Far East) Index (MSCI Standard Index Series, net of withholding tax) is an independently maintained and widely publishedindex comprised of international large and mid capitalization stocks. The MSCI EAFE + (Europe, Australasia, and Far East) Index is an internally maintained benchmarkcomputed by GMO, comprised of (i) the MSCI EAFE (Europe, Australasia, and Far East) Value Index (MSCI Standard Index Series, net of withholding tax) through06/30/2014 and (ii) the MSCI EAFE (Europe, Australasia, and Far East) Index (MSCI Standard Index Series, net of withholding tax) thereafter. MSCI data may not bereproduced or used for any other purpose. MSCI provides no warranties, has not prepared or approved this report, and has no liability hereunder.

    3The groups indicated above represent exposures determined pursuant to proprietary methodologies and are subject to change over time.4The above information is based on a representative account in the Strategy selected because it has the fewest restrictions and best represents the implementation of the

    Strategy.5Alpha is a measure of risk-adjusted return; Beta is a measure of a portfolios sensitivity to the market; R2 is a measure of how well a portfolio tracks the market;

    Sharpe Ratio is the return over the risk free rate per unit of risk; Std. Deviation is a measure of the volatility of a portfolio. Risk profile data is net.6Portfolio holdings are subject to change and should not be considered a recommendation to buy individual securities.

    Strategy Benchmark

    Price/Earnings - Hist 1 Yr Wtd Med 14.5 x 17.5 xPr ice/Cash Flow - Hist 1 Yr Wtd Med 6.5 x 10.9 xPrice/Book - Hist 1 Yr Wtd Avg 1.3 x 1.7 xReturn on Equity - Hist 1 Yr Med 9.8 % 11.2 %Market Cap - Weighted Median $Bil $36.1 $35.4Dividend Yield - Hist 1 Yr Wtd Avg 3.6 % 3.0 %

    Company Country Sector % of Equi ty

    Total S.A. France Energy 5.5Royal Dutch Shell PLC United Kingdom Energy 4.7

    BP PLC United Kingdom Energy 3.8DaimlerChrysler AG Germany Consumer Discretionary 2.6Telefonica S .A. Spain Telecommunication Services 2.6

    Total 19.2

    0

    20

    40

    60

    80

    100

    Europe Value, 76.4

    Other Int'l. Opportunistic Value, 4.1Cash & Cash Equiv., 3.0

    Japan, 16.4

    Intl. Developed Equity Cash

    19.1

    17.6

    16.4

    16.2

    6.1

    10.1

    21.4

    20.2

    9.3

    2.6

    0 5 10 15 20 25

    France

    United Kingdom

    Japan

    Germany

    Italy

    Strategy Benchmark

    Total Return (%) Average Annual Total Return (%)

    2Q YTD One Five Ten Since

    2014 2014 Year Year Year Inception

    Strategy 5.22 8.73 32.01 11.75 7.07 8.62MSCI EAFE

    24.09 4.78 23.57 11.77 6.93 5.70

    MSCI EAFE + 2

    4.73 6.01 26.86 11.24 6.71 7.48

    Annu al Tota l Retu rn (%)

    2004 2005 2006 2007 2008 2009 2010 2011 2012 2013

    Strategy 25.23 13 .98 25.78 10 .21 -40 .31 21.41 7 .53 -10.18 12.98 25.62

    MSCI EAFE 20.25 13.54 26.34 11.17 -43.38 31.78 7 .75 -12.14 17.32 22.78

    MSCI EAFE + 24.33 13.80 30.38 5.96 -44 .09 34.23 3.25 -12.17 17.69 22.95

    Strategy MSCI EAFE +

    Alpha 1.39 0.00

    Beta 0.92 1.00

    R2

    0.98 1.00

    Sharpe Ratio 0.70 0.62

    Std. Deviation 16.72 17.96

    28

  • 8/12/2019 GMO Quarterly Update Q2 2014

    30/62

    As of June 30, 2014

    GMO 2014

    Quarterly Strategy Attribut ion

    Performance data quoted represents past performance and is not predictive of future performance. Returns are shown after the deduction of management fees,transaction costs and other expenses, but before custody charges, withholding taxes, and other indirect expenses. The returns assume the reinvestment of dividends andother income.

    Quarterly Strategy Attribution

    GMO International Equity StrategyInception: 3/31/87; Benchmark: MSCI EAFE Index

    (The GMO International Equity Strategy was formerly known as the GMO International Intrinsic Value Strategy. GMO renamed the Strategy on June 30,

    2014.)

    29

  • 8/12/2019 GMO Quarterly Update Q2 2014

    31/62

    As of June 30, 2014

    GMO 2014

    GMO International Active EAFE StrategyInception: 5/31/81; Benchmark: MSCI EAFE Index

    Performance Net of Fees1 Top Overweight Holdings2,5

    5-Year Risk Profi le4

    1Performance data quoted represents past performance and is not predictive of future performance. Returns are shown after the deduction of management fees,transaction costs and other expenses, but before custody charges, withholding taxes, and other indirect expenses. The returns assume the reinvestment of dividends andother income.

    2Portfolio holdings are percent of equity. They are subject to change and should not be considered a recommendation to buy individual securities.3The MSCI EAFE (Europe, Australasia, and Far East) Index (MSCI Standard Index Series, net of withholding tax) is an independently maintained and widely published

    index comprised of international large and mid capitalization stocks. MSCI data may not be reproduced or used for any other purpose. MSCI provides no warranties, hasnot prepared or approved this report, and has no liability hereunder.

    4Alpha is a measure of risk-adjusted return; Beta is a measure of a portfolios sensitivity to the market; R2 is a measure of how well a portfolio tracks the market;Sharpe Ratio is the return over the risk free rate per unit of risk; Standard Deviation is a measure of the volatility of a portfolio. Risk profile data is net.

    5The above information is based on a representative account in the Strategy selected because it has the fewest restrictions and best represents the implementation of theStrategy.

    Sector Weights5

    GICS Sectors

    Region Weights 5

    Characteristics5

    Total Return (%) Average Annual Total Return (%)

    2Q YTD One Five Ten Since2014 2014 Year Year Year Inception

    Strategy 2.99 1.93 21.97 10.39 6.34 12.15Benchmark 3 4.09 4.78 23.57 11.77 6.93 9.32

    An nua l To ta l Return (%)

    2004 2005 2006 2007 2008 2009 2010 2011 2012 2013

    Strategy 22.33 13.52 27.52 10.58 -41.24 25.53 5.01 -11.65 14.92 24.11

    Benchmark 20.25 13.54 26.34 11.17 -43.38 31.78 7.75 -12.14 17.32 22.78

    Underweight/Overweight

    Regi on Agai nst Benchmark (%)

    Australia/New Zealand

    Emerging

    Europe ex UK

    JapanSoutheast Asia

    United Kingdom

    Cash + Unrealized G/L

    -5.4

    5.7

    6.0

    -2.6

    -2.0

    -2.7

    0.9

    -10 -5 0 5 10

    Underweight/OverweightSector Agai nst Benchmark Strategy Benchmark

    Consumer Discretionary 13.5 % 11.9 %Consumer Staples 6.7 11.1Energy 13.2 7.3Financials 24.7 25.3Health Care 4.7 10.5Industrials 10.3 12.7Information Technology 8.6 4.4Materials 4.0 8.0Telecom. Serv ices 4.2 4.9Utilities 10.0 3.96.1

    -0.7

    -4.04.2

    -2.4

    -5.8

    -0.6

    5.9-4.4

    1.6

    -10 -5 0 5 10

    St r a teg y B en ch ma rk

    Alpha -1.40 0.00

    Beta 1.00 1.00

    R2

    0.98 1.00Sharpe Ratio 0.60 0.69

    Std. Deviation 17.09 16.90

    St ra teg y Ben ch ma rk

    Price/Earnings - Hist 1 Yr Wtd Med 16.3 x 17.5 x

    Pri ce/Cash Flow - Hist 1 Yr Wtd Med 7.5 x 10.9 x

    Price/Book - Hist 1 Yr Wtd Avg 1.4 x 1.7 x

    Dividend Yield - Hist 1 Yr Wtd Avg 2.9 % 3.0 %

    Peugeot S.A. 3.2%

    Sumitomo Mitsui Financial 3.1%

    Mitsubishi Tokyo Financial 3.0%

    Samsung Elect ronics Co. 3 .0%

    E.ON AG 2.9%

    RWE AG 2.0%Eni S.p.A. 1.9%

    Nokia Corp. 1.8%

    Repsol YPF S.A. 1.4%

    British American Tobacco 1.3%

    30

  • 8/12/2019 GMO Quarterly Update Q2 2014

    32/62

    As of June 30, 2014

    GMO 2014

    Quarterly Strategy Attribut ion

    Performance data quoted represents past performance and is not predictive of future performance. Returns are shown after the deduction of management fees,transaction costs and other expenses, but before custody charges, withholding taxes, and other indirect expenses. The returns assume the reinvestment of dividends andother income.

    GMO International Active EAFE StrategyInception: 5/31/81; Benchmark: MSCI EAFE Index

    The International Active EAFE Strategy gained 3.0% net of fees in the second quarter, 1.1 percentage points behind the MSCI EAFEindex, which returned +4.1%.

    Country selection was behind the benchmark. Our positioning in Continental Europe subtracted from returns, particularly overweightpositions in Italy and France, which underperformed in the quarter.

    Stock selection also lagged the benchmark in the second quarter. Holdings in the United Kingdom and Japan underperformed. Onthe positive side, stock selection in Continental Europe helped returns.

    31

  • 8/12/2019 GMO Quarterly Update Q2 2014

    33/62

    As of June 30, 2014

    GMO 2014

    GMO Intl. Active Foreign Small Companies StrategyInception: 1/31/95; Benchmark: S&P Developed ex-U.S. Small Cap Index

    Performance Net of Fees1 Top Overweight Holdings2,5

    5-Year Risk Profi le4

    1Performance data quoted represents past performance and is not predictive of future performance. Returns are shown after the deduction of management fees,transaction costs and other expenses, but before custody charges, withholding taxes, and other indirect expenses. The returns assume the reinvestment of dividends andother income.

    2Portfolio holdings are percent of equity. They are subject to change and should not be considered a recommendation to buy individual securities.3The S&P Developed ex-U.S. Small Cap Index is an independently maintained and widely published index comprised of the small capitalization stock component of the

    S&P Broad Market Index (BMI). The BMI includes listed shares of companies from developed and emerging countries with a total available market capitalization (float)of at least the local equivalent of $100 million USD. The S&P Developed ex-U.S. Small Cap Index represents the bottom 15% of available market capitalization (float) ofthe BMI in each country.

    4Alpha is a measure of risk-adjusted return; Beta is a measure of a portfolios sensitivity to the market; R2 is a measure of how well a portfolio tracks the market;Sharpe Ratio is the return over the risk free rate per unit of risk; Standard Deviation is a measure of the volatility of a portfolio. Risk profile data is net.

    5The above information is based on a representative account in the Strategy selected because it has the fewest restrictions and best represents the implementation of theStrategy.

    Sector Weights 5Region Weights5

    Characteristics5

    GICS Sectors

    Total Return (%) Average Annual Total Return (%)

    2Q YTD One Five Ten Since2014 2014 Year Year Year Inception

    Strategy 1.90 5.02 25.85 17.31 11.13 11.94Benchmark 3 3.40 7.24 29.95 15.47 9.64 7.90

    An nu al To ta l Retur n (%)

    2004 2005 2006 2007 2008 2009 2010 2011 2012 2013

    Strategy 29.30 18.91 36.24 8.00 -45.91 47.63 24.76 -15.21 21.64 28.92

    Benchmark 28.73 22.10 29.42 7.32 -47.67 45.07 21.96 -14.49 18.55 26.06

    St ra teg y Ben ch ma rk

    Price/Earnings - Hist 1 Yr Wtd Med 19.2 x 20.2 x

    Pri ce/Cash Flow - Hist 1 Yr Wtd Med 11.4 x 12.2 x

    Price/Book - Hist 1 Yr Wtd Avg 1.6 x 1.6 x

    Dividend Yield - Hist 1 Yr Wtd Avg 2.1 % 2.3 %

    Underweight/Overweight

    Regi on Agai nst Benchmark (%)

    Australia/New Zealand

    Canada

    Emerging

    Europe ex UKJapan

    Southeast Asia

    United Kingdom

    Cash + Unrealized G/L

    0.6

    -2.5

    3.7

    3.5

    -2.8

    -3.5

    -1.2

    2.3

    -6 -3 0 3 6

    Underweight/Overweightec or ga ns enc mar ra egy enc mar

    Consumer Discretionary 21.9 % 16.4 %Consumer Staples 3.2 5.6Energy 7.5 4.9Financials 20.9 21.6

    Health Care 3.4 6.0Industrials 24.2 23.0Information Technology 8.4 8.8Materials 9.5 10.3Telecom. Serv ices 0.9 1.2Utilities 0.0 2.3-2.3

    -0.3

    -0.8

    -0.4

    1.2-2.6

    -0.7

    2.6

    -2.4

    5.5

    -6 -3 0 3 6

    St r a t eg y B en ch ma rk

    Alpha 2.49 0.00

    Beta 0.96 1.00

    R2

    0.98 1.00Sharpe Ratio 1.03 0.89

    Std. Deviation 16.66 17.20

    Mediobanca Banca di Credito 1.4%

    Capstone Mining Corp. 1.3%

    Credito Emiliano S.p.A. 1.2%

    Asciano Group 1.2%

    NuVista Energy Ltd. 1.2%

    Incitec Pivot Ltd. 1.2%Groupe Steria S.C.A. 1.2%

    Rheinmetall AG 1.2%

    Precision Drilling Corp. 1.1%

    Vicat S .A. 1.1%

    32

  • 8/12/2019 GMO Quarterly Update Q2 2014

    34/62

    As of June 30, 2014

    GMO 2014

    Quarterly Strategy Attribut ion

    Performance data quoted represents past performance and is not predictive of future performance. Returns are shown after the deduction of management fees,transaction costs and other expenses, but before custody charges, withholding taxes, and other indirect expenses. The returns assume the reinvestment of dividends andother income.

    The International Active Foreign Small Companies Strategy underperformed the S&P Developed ex-U.S. Small Cap index by 1.5percentage points in the second quarter, gaining 1.9% net of fees while the benchmark rose 3.4%.

    Country selection was behind the benchmark in the quarter. Our positioning in Continental Europe hurt returns, particularlyoverweight positions in Italy and France, which underperformed in the quarter. An underweight position in Japan also subtracted from

    returns.

    Stock selection outperformed the benchmark, but it was not enough to offset the negative country selection. Our holdings in Japan,Australia, and the emerging markets outperformed. Stock selection in Continental Europe and the United Kingdom hurt performance.

    GMO Intl. Active Foreign Small Companies StrategyInception: 1/31/95; Benchmark: S&P Developed ex-U.S. Small Cap Index

    33

  • 8/12/2019 GMO Quarterly Update Q2 2014

    35/62

    As of June 30, 2014

    GMO 2014

    GMO U.S. Equity Allocation StrategyInception: 2/28/89; Benchmark: Russell 3000 Index

    GICS Sectors

    1Performance data quoted represents past performance and is not predictive of future performance. Returns are shown after the deduction of management fees,transaction costs and other expenses, but before custody charges, withholding taxes, and other indirect expenses. The returns assume the reinvestment of dividends andother income.

    2The GMO blended U.S. Equity Allocation Composite benchmark is comprised of a weighted average of account benchmarks; many of the account benchmarks consist ofS&P 500, Russell 3000 or some like proxy for each market exposure they have. For each underlying account benchmark, the weighting of each market index will varyslightly. The index is internally blended by GMO and maintained on a monthly basis. Russell Investments is the source and owner of the Russell index data contained orreflected in this material and all trademarks and copyrights related thereto. The presentation may contain confidential information and unauthorized use, disclosure,copying, dissemination or redistribution is strictly prohibited. This is GMOs presentation of the data. FCR is not responsible for the formatting or configuration of thismaterial or for any inaccuracy in GMOs presentation thereof.

    3The groups indicated above represent exposures determined pursuant to proprietary methodologies and are subject to change over time.4The above information is based on a representative account in the Strategy selected because it has the fewest restrictions and best represents the implementation of the

    Strategy.5Alpha is a measure of risk-adjusted return; Beta is a measure of a portfolios sensitivity to the market; R2 is a measure of how well a portfolio tracks the market;

    Sharpe Ratio is the return over the risk free rate per unit of risk; Std. Deviation is a measure of the volatility of a portfolio. Risk profile data is net.6Portfolio holdings are subject to change and should not be considered a recommendation to buy individual securities.

    Performance Net of Fees1

    5-Year Risk Profi le5

    Top Holdings4,6

    Sector Weights (%)4Group Exposures (%)3,4

    Characteristics4

    Total Return (%) Average Annual Total Return (%)

    2Q YTD One Five Ten Since2014 2014 Year Year Year Inception

    Strategy 3.34 5.53 18.05 16.46 6.90 10.83Benchmark 2 5.23 7.14 24.86 19.15 8.05 10.36

    Annu al Total Retu rn (%)

    2004 2005 2006 2007 2008 2009 2010 2011 2012 2013

    Strategy 10.74 3.68 9.93 2.25 -27.87 20.54 7.43 9.91 12.25 27.95

    Benchmark 11.45 5.53 15.71 5.39 - 37.15 27.46 16 .26 1.58 16.21 32.85

    0

    20

    40

    60

    80

    100

    U.S. Quality, 74.9

    U.S. Opportunistic Value, 23.1

    Cash & Cash Equiv., 1.9

    U.S. Equity Cash

    5.1

    17.1

    12.7

    5.3

    18.9

    6.3

    33.5

    1.2

    0.0

    0.0

    11.9

    9.5

    10.9

    16.1

    13.210.5

    18.9

    3.5

    2.4

    3.2

    0 10 20 30 4

    Consumer Discretionary

    Consumer Staples

    Energy

    Financials

    Health CareIndustrials

    Information Technology

    Materials

    Telecommunication Services

    Utilities

    Strategy Benchmark

    St r at eg y Ben ch ma rk

    Price/Earnings - Hist 1 Yr Wtd Median 17.7 x 19.5 xPrice/Book - Hist 1 Yr Wtd Avg 3.2 x 2.7 x

    Return on Equity - Hist 1 Yr Median 21.8 % 17.4 %

    Market Cap -Weighted Median $Bil $132.9 $68.3

    Dividend Yield - Hist 1 Yr Wtd Avg 2.1 x 2.0 x

    ompany ec or o qu y

    Oracle Corp. Information Technology 5.3

    Philip Morris Int 'l. Inc. Consumer St aples 5.0

    Chevron Corp. Energy 5.0

    Microsoft Corp. Informat ion Technology 4.7

    Int'l. Business Machines Information Technology 4.3

    Total 24.3

    St ra teg y Ben ch ma rk

    Alpha 1.19 0.00

    Beta 0.80 1.00

    R2

    0.90 1.00

    Sharpe Ratio 1.44 1.40

    Std. Deviation 11.38 13.57

    34

  • 8/12/2019 GMO Quarterly Update Q2 2014

    36/62

    As of June 30, 2014

    GMO 2014

    Quarterly Strategy Attribut ion

    Performance data quoted represents past performance and is not predictive of future performance. Returns are shown after the deduction of management fees,transaction costs and other expenses, but before custody charges, withholding taxes, and other indirect expenses. The returns assume the reinvestment of dividends andother income.

    GMO U.S. Equity Allocation StrategyInception: 2/28/89; Benchmark: Russell 3000 Index

    35

  • 8/12/2019 GMO Quarterly Update Q2 2014

    37/62

    As of June 30, 2014

    GMO 2014

    GMO Emerging Markets StrategyInception: 12/31/93; Benchmark: S&P/IFCI Composite Index

    Performance Net of Fees1 Top Ten Holdings2,5

    5-Year Risk Profi le4

    1Performance data quoted represents past performance and is not predictive of future performance. Returns are shown after the deduction of management fees,transaction costs and other expenses, but before custody charges, withholding taxes, and other indirect expenses. The returns assume the reinvestment of dividends andother income.

    2Portfolio holdings are percent of equity. They are subject to change and should not be considered a recommendation to buy individual securities.3The S&P/IFCI Composite Index is an independently maintained and widely published index comprised of emerging markets stocks. S&P does not guarantee the

    accuracy, adequacy, completeness or availability of any data or information and is not responsible for any errors or omissions from the use of such data or information.Reproduction of the data or information in any form is prohibited except with the prior written permission of S&P or its third party licensors.

    4Alpha is a measure of risk-adjusted return; Beta is a measure of a portfolios sensitivity to the market; R2 is a measure of how well a portfolio tracks the market;Sharpe Ratio is the return over the risk free rate per unit of risk; Std. Deviation is a measure of the volatility of a portfolio. Risk profile data is net.

    5The above information is based on a representative account in the Strategy selected because it has the fewest restrictions and best represents the implementation of theStrategy.

    Sector Weights5

    GICS Sectors

    Region Weights5

    Characteristics5

    Total Return (%) Average Annual Total Return (%)

    2Q YTD One Five Ten Since2014 2014 Year Year Year Inception

    Strategy 8.13 4.95 13.39 8.51 11.07 8.05Benchmark 3 7.51 6.82 16.00 10.14 12.91 6.28

    Annu al Tota l Retu rn (%)

    2004 2005 2006 2007 2008 2009 2010 2011 2012 2013

    Strategy 26.54 40.15 29.51 37.22 -55.74 71.89 20.20 -16.95 15.19 -5.19

    Benchmark 28.11 35.19 35.11 40.28 -53.74 81.03 20.64 -19.03 18.89 -0.57

    St ra teg y B en ch ma rk

    Alpha -1.87 0.00

    Beta 1.02 1.00R

    20.98 1.00

    Sharpe Ratio 0.43 0.53

    Std. Deviation 19.67 18.96

    Samsung Electronics Co. Ltd. 3.9%

    Gazprom OAO 2.9%

    China Const ruct ion Bank 2.7%

    China Mobile Ltd. 2.6%

    Surgutneftegaz 2.6%LukOil OAO 2.5%

    KGHM Polska Miedz S.A. 2.3%

    Ind. & Comm. Bank of China 2.3%

    Banco do Brasil S.A. 2.1%

    Bank of China Ltd. 2.0%

    Total 25.9%

    St r at eg y Ben ch ma rk

    Price/Earnings - Hist 1 Yr Wtd Med 10.6 x 16.2 x

    Price/Cash Flow - Hist 1 Yr Wtd Med 5.9 x 10.0 xPrice/Book - Hist 1 Yr Wtd Avg 1.1 x 1.5 x

    Return on Equity - Hist 1 Yr Avg 12.2 % 11.4 %

    Market Cap -Weighted Median $Bil $6.7 $7.3

    Number of Equity Holdings 430 2,199

    Dividend Yield - Hist 1 Yr Wtd Avg 4.1 % 2.7 %

    Underweight/Overweight

    Region Against Benchmark (%)

    DevelopedEast Asia

    Europe

    Latin/South America

    Mideast/Africa

    South Asia

    Cash + Unrealized G/L

    1.3

    -8.3

    13.9

    -1.5

    -4.1

    -1.5

    0.2

    -20 -10 0 10 20

    Underweight/Overweight

    Sector Against Benchmark Strategy Benchmark

    Consumer Discretionary 6.4 % 10.2 %

    Consumer Staples 1.8 8.3Energy 17.7 9.6Financials 24.9 25.4Health Care 1.1 2.4Industrials 3.3 7.5Information Technology 13.9 17.9Materials 8.6 9.1

    Telecom. Services 13.1 6.3Utilities 9.2 3.35.9

    6.8

    -0.5

    -4.0

    -4.2

    -1.3

    -0.5

    8.1

    -6.5

    -3.8

    -10 -5 0 5 10

    36

  • 8/12/2019 GMO Quarterly Update Q2 2014

    38/62

    As of June 30, 2014

    GMO 2014

    Quarterly Strategy Attribut ion

    Performance data quoted represents past performance and is not predictive of future performance. Returns are shown after the deduction of management fees,transaction costs and other expenses, but before custody charges, withholding taxes, and other indirect expenses. The returns assume the reinvestment of dividends andother income.

    GMO Emerging Markets StrategyInception: 12/31/93; Benchmark: S&P/IFCI Composite Index

    The Emerging Markets Strategy jumped 8.1% net of fees in the second quarter, outperforming the 7.5% rise in the S&P/IFCIComposite by 0.6%. Overall, country-sector allocation gained 0.4% and stock selection added 0.2%.

    Emerging markets went on a bull run in the second quarter. Investor sentiment was boosted by the low valuations, continuingrecovery in the U.S., reduced political uncertainty in Ukraine, and an overwhelming mandate for the winning party in Indian elections.

    Also helping were reports in June of Chinese manufacturing rising at the fastest pace in seven months and a robust expansion inTaiwans factory output. Country returns varied over the quarter, ranging from a 15.1% jump in Turkey to a 10.8% drop in Greece.Sector returns were all positive and more clustered, varying from an 11.2% leap in IT to a more modest return of +3.8% for Materials.

    Investor sentiment in Brazil improved with continuing drops in the governments approval rating. Elections are due in October of2014 and speculation of a change in leadership lifted the market as the current government is seen as prone to micro-managing theeconomy. Investors expect the opposition to be less inclined to intervene in state-run companies and more focused on reining ininflation. Our overweight in Brazilian Utilities contributed to performance.

    The Indian stock market soared after national elections delivered a much stronger mandate than expected. The winning partysinglehandedly won a majority of seats, a feat unattained in the last 30 years. Narendra Modi, the newly elected prime minister, isexpected to quickly take concrete steps to boost economic growth. Our underweight in Indian Energy and Industrials hurtperformance.

    The Russian stock market continued its run on the back of easing tensions with Ukraine. Russian president Putin asked lawmakers torevoke his authority to use force in Ukraine - a conciliatory gesture after his meeting with the Ukrainian president. Also helping themarket was a jump in oil prices amid turmoil in Iraq and Syria. A $400 billion contract awarded to energy exporter OAO Gazprom tosupply fuel to China over 30 years also brought some cheer. Our overweight in Russian Energy boosted performance.

    Taiwanese stocks were buoyed by rising optimism for the U.S. and Taiwan economies. Taiwans industrial output rose 5.2% from ayear earlier in May, exceeding expectations. The central bank maintained interest rates at 1.875%. Our overweight in Taiwan IT addedto performance.

    The stock market in Turkey rebounded after the ruling party won local elections. Investors read that as a sign that the political crisisthat began last December was coming to an end. The central bank unexpectedly cut its repurchase rate to 9.5% from 10% and floatedthe possibility of further rate cuts. Toward the end of the quarter, the stock market gave back some of its gains on political tension inIraq, a key trading partner, and on rising oil prices, a driver of its worrisome current account deficit. Our overweight in TurkishFinancials helped performance.

    Stock selection was additive to performance with particularly strong selection in China Financials and India Financials.

    37

  • 8/12/2019 GMO Quarterly Update Q2 2014

    39/62

    As of June 30, 2014

    GMO 2014

    GMO Emerging Domestic Opportunities StrategyInception: 3/31/11

    Performance Net of Fees1 Top Ten Holdings2,6

    Risk Profile Since 3/31/114

    GICS Sectors

    1Performance data quoted represents past performance and is not predictive of future performance. Returns are shown after the deduction of management fees,transaction costs and other expenses, but before custody charges, withholding taxes, and other indirect expenses. The returns assume the reinvestment of dividends andother income.

    2Portfolio holdings are percent of equity. They are subject to change and should not be considered a recommendation to buy individual securities.3The Emerging Domestic Opportunities Strategy does not have a benchmark. The Strategy has been compared to the MSCI Emerging Markets Index in an eff